Pharmacists: Integral to the Management of Chemotherapy-Induced Nausea and Vomiting (ASCO/article/response)

Pharmacists: Integral to the Management of Chemotherapy-Induced Nausea and Vomiting

To the Editor:

We are surprised that the recently updated ASCO antiemetic guideline excludes pharmacists as a targeted audience.¹

 REFERENCES

1. 1.↵
   1. Hesketh PJ,
   2. Bohlke K,
   3. Lyman GH,
   4. et al.

   (2016) Antiemetics: American Society of Clinical Oncology focused guideline update. J Clin Oncol 34:381–386.

   Abstract/FREE Full Text
2. 2.↵
   National Comprehensive Cancer Network: Antiemesis, version 2.2015. Jenkintown, PA, National Comprehensive Cancer Network, 2015.
3. 3.↵
   Cancer Care Ontario Antiemetic Working Group: Antiemetic report: Clinical evidence for recommendations. Toronto, Ontario, Canada, Cancer Care Ontario, 2013.
4. 4.↵
   1. Lee Dupuis L,
   2. Robinson PD,
   3. Boodhan S,
   4. et al.

   (2014) Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients (Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada).

   Google Scholar
5. 5.↵
   American Society of Clinical Oncology: The state of cancer care in America, 2014: A report by the American Society of Clinical Oncology. J Oncol Pract 10:119-142, 2014.

Related Article

• CORRESPONDENCE: Reply to J. Jupp et al

  • Paul J. Hesketh,
  • Kari Bohlke,
  • and Mark G. Kris

  JCO JCO686147; published online on July 18, 2016;
  • [Full Text]
  • [PDF]

Article/Correspondence: Symptom monitoring with patient-reported outcomes during routine cancer treatment

CORRESPONDENCE Symptom Improvement Requires More Than Screening and Feedback

• Kurt Kroenke and
• Andrea Lynne Cheville

JCO published online on July 18, 2016; DOI:10.1200/JCO.2016.67.7708.

• [Full Text]
• [PDF]

CORRESPONDENCE Reply to K. Kroenke et al

• Ethan Basch

JCO published online on July 18, 2016; DOI:10.1200/JCO.2016.67.9480.

• [Full Text]
• [PDF] 
•  
  

  REFERENCES

• 1.↵
  1. Kroenke K,
  2. Cheville AL

  Symptom improvement requires more than screening and feedback. J Clin Oncol, doi:10.1200/JCO.2016.67.7708.
• 2.↵
  1. Basch E,
  2. Deal AM,
  3. Kris MG,
  4. et al.

  (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol 34:557–565.

  Abstract/FREE Full Text

8th Edition UICC TNM Classification Tumours Jan 2017 Ovary, FT, PP

2014/2016 TNM and Ovary, Fallopian Tube and primary peritoneal carcinoma FIGO